|
 FDA
Warns Consumers to Stop Using Lipokinetix
Auburn,
Nov. 30---The Food and Drug Administration (FDA) is warning
consumers to immediately stop using Lipokinetix. Marketed as a
dietary supplement for weight loss by Syntrax Innovations Inc.,
Lipokinetix has been implicated in a number of serious liver
injuries. The FDA received multiple reports of persons who developed
liver injury or liver failure while using the supplement. The liver
injuries occurred in persons between 20 and 32 years of age. Liver
injury developed between two weeks and three months of Lipokinetix
use.
The FDA also urges
consumers to consult their physician if they are experiencing
symptoms associated with Lipokinetix, especially nausea, weakness or
fatigue, abdominal pain or any change in skin color.
SOURCE: Dr. Barbara
Struempler, Extension Nutritionist, Alabama Cooperative Extension
System, (334) 844-2217
|
